Trademark: 85683761
Word
NEURIMMUNE
Status Date
Friday, March 18, 2022
Registration Number
4806264
Registration Date
Tuesday, September 8, 2015
Filing Date
Sunday, July 22, 2012
Published for Opposition
Tuesday, April 29, 2014
Cancellation Date
Friday, March 18, 2022
5 Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical and veterinary use; sanitary towels; dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely, dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely, dietetic tea; low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely, low calorie or reduced calorie fruit beverages: protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases
44 Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
42 Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; consultation and providing information about testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testing, inspection or research of medical treatment and technique; scientific research about health care; biology research; computer software design, computer programming, or maintenance of computer software; computer hardware design and development; computer software design and development
The mark consists of the word "neurimmune" and a line design.
Color is not claimed as a feature of the mark.
Mar 18, 2022
Cancelled Sec. 8 (6-Yr)
Jul 21, 2021
Teas Change Of Correspondence Received
Jul 21, 2021
Teas Change Of Domestic Representatives Address
Jul 21, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 21, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 8, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 10, 2016
Teas Change Of Correspondence Received
Sep 8, 2015
Registered-Principal Register
Aug 7, 2015
Notice Of Reinstatement Mailed
Aug 6, 2015
1(B) Basis Deleted; Proceed To Registration
Jun 24, 2015
Notice Of Allowance Cancelled
Aug 6, 2015
Reinstatement Granted - Request To Delete 1(B) Filed
Jul 27, 2015
Abandonment Notice Mailed - No Use Statement Filed
Jul 27, 2015
Abandonment - No Use Statement Filed
Jun 11, 2015
Teas Post Publication Amendment Received
Nov 25, 2014
Notice Of Approval Of Extension Request E-Mailed
Nov 21, 2014
Sou Extension 1 Granted
Nov 21, 2014
Sou Extension 1 Filed
Nov 21, 2014
Teas Extension Received
Sep 4, 2014
Changes/Corrections After Pub Approval Entered
Jul 9, 2014
Assigned To Petition Staff
May 14, 2014
Post Publication Amendment Received
Jun 24, 2014
Noa E-Mailed - Sou Required From Applicant
May 14, 2014
Teas Delete 1(B) Basis Received
Apr 29, 2014
Official Gazette Publication Confirmation E-Mailed
Apr 29, 2014
Published For Opposition
Apr 9, 2014
Notification Of Notice Of Publication E-Mailed
Mar 27, 2014
Law Office Publication Review Completed
Mar 17, 2014
Approved For Pub - Principal Register
Mar 14, 2014
Teas/Email Correspondence Entered
Mar 14, 2014
Correspondence Received In Law Office
Mar 14, 2014
Teas Response To Office Action Received
Feb 5, 2014
Notification Of Non-Final Action E-Mailed
Feb 5, 2014
Non-Final Action E-Mailed
Feb 5, 2014
Non-Final Action Written
Feb 5, 2014
Previous Allowance Count Withdrawn
Feb 4, 2014
Case Returned To Examination
Feb 4, 2014
Notice Of Allowance Cancelled
Dec 17, 2013
Noa E-Mailed - Sou Required From Applicant
Oct 22, 2013
Official Gazette Publication Confirmation E-Mailed
Oct 22, 2013
Published For Opposition
Oct 2, 2013
Notification Of Notice Of Publication E-Mailed
Sep 18, 2013
Law Office Publication Review Completed
Sep 17, 2013
Approved For Pub - Principal Register
Sep 16, 2013
Teas/Email Correspondence Entered
Sep 16, 2013
Correspondence Received In Law Office
Sep 16, 2013
Teas Response To Office Action Received
Mar 22, 2013
Notification Of Non-Final Action E-Mailed
Mar 22, 2013
Non-Final Action E-Mailed
Mar 22, 2013
Non-Final Action Written
Mar 19, 2013
Teas/Email Correspondence Entered
Mar 18, 2013
Correspondence Received In Law Office
Mar 18, 2013
Teas Response To Office Action Received
Feb 28, 2013
Notification Of Non-Final Action E-Mailed
Feb 28, 2013
Non-Final Action E-Mailed
Feb 28, 2013
Non-Final Action Written
Feb 14, 2013
Teas/Email Correspondence Entered
Feb 14, 2013
Correspondence Received In Law Office
Feb 5, 2013
Assigned To Lie
Feb 4, 2013
Teas Response To Office Action Received
Oct 9, 2012
Notification Of Non-Final Action E-Mailed
Oct 9, 2012
Non-Final Action E-Mailed
Oct 9, 2012
Non-Final Action Written
Oct 5, 2012
Assigned To Examiner
Aug 13, 2012
Teas Amendment Entered Before Attorney Assigned
Aug 13, 2012
Teas Voluntary Amendment Received
Jul 28, 2012
Notice Of Design Search Code Mailed
Jul 27, 2012
New Application Office Supplied Data Entered In Tram
Jul 25, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
